Search Results - "Gill, Ss"

Refine Results
  1. 1

    Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model by Singleton, W G, Collins, A M, Bienemann, A S, Killick-Cole, C L, Haynes, H R, Asby, D J, Butts, C P, Wyatt, M J, Barua, N U, Gill, S S

    Published in International journal of nanomedicine (01-01-2017)
    “…The pan-histone deacetylase inhibitor panobinostat is a potential therapy for malignant glioma, but it is water insoluble and does not cross the blood-brain…”
    Get full text
    Journal Article
  2. 2

    Gene Expression Changes Induced in Mouse Liver by Di(2-ethylhexyl) Phthalate by Wong, Jean S., Gill, Sarjeet S.

    Published in Toxicology and applied pharmacology (15-12-2002)
    “…Increasing chemical use necessitates a better understanding of how pollutants, such as di(2-ethylhexyl) phthalate (DEHP), a peroxisome proliferator and a…”
    Get full text
    Journal Article
  3. 3

    Design of Transfer Learning based Deep CNN Paradigm for Brain Tumor Classification by Bhardwaj, Neha, Sood, Meenakshi, Gill, Ss

    “…Brain tumor is a fatal illness causing worldwide fatalities. The existing neuroimaging modalities to detect brain tumors are invasive and are observer-biased…”
    Get full text
    Journal Article
  4. 4

    Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinsonʼs disease by Plaha, Puneet, Gill, Steven S

    Published in Neuroreport (28-11-2005)
    “…Gait disturbance and postural instability are some the most disabling symptoms of idiopathic Parkinsonʼs disease and in late stage disease can be resistant to…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis by Etminan, Mahyar, Gill, Sudeep S, Samii, Ali

    Published in Lancet neurology (01-06-2005)
    “…We studied the effect of vitamin C, vitamin E, and beta carotene intake on the risk of Parkinson's disease (PD). We did a systematic review and meta-analysis…”
    Get more information
    Journal Article
  7. 7

    Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: A two-year outcome study by Patel, Nikunj K., Bunnage, Martin, Plaha, Puneet, Svendsen, Clive N., Heywood, Peter, Gill, Steven S.

    Published in Annals of neurology (01-02-2005)
    “…We have shown previously that intraparenchymal infusion of glial cell line–derived neurotrophic factor (GDNF) continuously into the posterior putamen in five…”
    Get full text
    Journal Article
  8. 8

    Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease by Gill, Steven S, Svendsen, Clive N, Patel, Nikunj K, Hotton, Gary R, O'Sullivan, Karen, McCarter, Renée, Bunnage, Martin, Brooks, David J, Heywood, Peter

    Published in Nature medicine (01-05-2003)
    “…Glial cell line-derived neurotrophic factor (GDNF) is a potent neurotrophic factor with restorative effects in a wide variety of rodent and primate models of…”
    Get full text
    Journal Article
  9. 9

    Oligomerization triggers binding of a Bacillus thuringiensis Cry1Ab pore-forming toxin to aminopeptidase N receptor leading to insertion into membrane microdomains by Bravo, A., Gómez, I., Conde, J., Muñoz-Garay, C., Sánchez, J., Miranda, R., Zhuang, M., Gill, S.S., Soberón, M.

    Published in Biochimica et biophysica acta (17-11-2004)
    “…Bacillus thuringiensis Cry1A toxins, in contrast to other pore-forming toxins, bind two putative receptor molecules, aminopeptidase N (APN) and cadherin-like…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study by Gill, Sudeep S, Rochon, Paula A, Herrmann, Nathan, Lee, Philip E, Sykora, Kathy, Gunraj, Nadia, Normand, Sharon-Lise T, Gurwitz, Jerry H, Marras, Connie, Wodchis, Walter P, Mamdani, Muhammad

    Published in BMJ (26-02-2005)
    “…Abstract Objective To compare the incidence of admissions to hospital for stroke among older adults with dementia receiving atypical or typical antipsychotics…”
    Get full text
    Journal Article
  12. 12

    Bacillus thuringiensis subsp. israelensis Cyt1Aa synergizes Cry11Aa toxin by functioning as a membrane-bound receptor by Perez, C, Fernandez, L.E, Sun, J, Folch, J.L, Gill, S.S, Soberon, M, Bravo, A

    “…Bacillus thuringiensis subsp. israelensis produces crystal proteins, Cry (4Aa, 4Ba, 10Aa, and 11Aa) and Cyt (1Aa and 2Ba) proteins, toxic to mosquito vectors…”
    Get full text
    Journal Article
  13. 13

    Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review by Lee, Philip E, Gill, Sudeep S, Freedman, Morris, Bronskill, Susan E, Hillmer, Michael P, Rochon, Paula A

    Published in BMJ (10-07-2004)
    “…Abstract Objective To review the role of oral atypical antipsychotic drugs in the management of the behavioural and psychological symptoms of dementia (BPSD)…”
    Get full text
    Journal Article
  14. 14

    A GPI-anchored alkaline phosphatase is a functional midgut receptor of Cry11Aa toxin in Aedes aegypti larvae by Fernandez, Luisa E, Aimanova, Karlygash G, Gill, Sarjeet S, Bravo, Alejandra, Soberón, Mario

    Published in Biochemical journal (15-02-2006)
    “…A 65 kDa GPI (glycosylphosphatidyl-inositol)-anchored ALP (alkaline phosphatase) was characterized as a functional receptor of the Bacillus thuringiensis…”
    Get full text
    Journal Article
  15. 15

    DIPG-42. THE COMBINATION OF THE CDK4/6 INHIBITOR PALBOCICLIB WITH THE RAPALOGUE TEMSIROLIMUS INHIBITS DIPG CELL PROLIFERATION VIA SYNERGISTIC ATTENUATION OF CELL CYCLE REGULATORS by Asby, DJ, Bienemann, AS, Wright, LJ, Killick-Cole, C, Singleton, WGB, Wyatt, MJ, Barua, NU, Gill, SS

    Published in Neuro-oncology (Charlottesville, Va.) (01-06-2017)
    “…Current chemotherapy for diffuse intrinsic pontine glioma (DIPG) is ineffective and requires revitalization. DIPG accounts for up to 15% of all childhood…”
    Get full text
    Journal Article
  16. 16

    TRTH-07. THE DISTRIBUTION, CLEARANCE AND TOXICITY OF PANOBINOSTAT ADMINISTERED TO JUVENILE RAT AND PIG BRAINSTEM BY CONVECTION ENHANCED DELIVERY by Singleton, WGB, Bienemann, AS, Wooley, M, Johnson, D, Lewis, O, Wyatt, MJ, White, LJ, Damment, SJP, Killick-Cole, C, Asby, DJ, Gill, SS

    Published in Neuro-oncology (Charlottesville, Va.) (01-06-2017)
    “…The pan-histone deacetylase inhibitor panobinostat has preclinical efficacy against DIPG and the oral formulation has entered a phase one clinical trial…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Nursing Home Profit Status and Quality of Care: Is There Any Evidence of an Association? by Hillmer, Michael P., Wodchis, Walter P., Gill, Sudeep S., Anderson, Geoffrey M., Rochon, Paula A.

    Published in Medical care research and review (01-04-2005)
    “…This article critically reviews the association between the profit status of North American nursing homes and the quality of care. Studies were identified by…”
    Get full text
    Journal Article
  19. 19

    Stimulation of the subthalamic region for essential tremor by PLAHA, Puneet, PATEL, Nikunj K, GILL, Steven S

    Published in Journal of neurosurgery (01-07-2004)
    “…The goal of this study was to determine the safety and efficacy of bilateral subthalamic region stimulation in the treatment of essential tremor (ET)…”
    Get full text
    Journal Article
  20. 20

    Unilateral subthalamotomy in the treatment of Parkinson’s disease by Patel, Nikunj K., Heywood, Peter, O’Sullivan, Karen, McCarter, Renée, Love, Seth, Gill, Steven S.

    Published in Brain (London, England : 1878) (01-05-2003)
    “…Hyperactivity in the subthalamic nucleus (STN) is seen in animal models of Parkinson’s disease, and lesioning of the STN dramatically relieves the animal’s…”
    Get full text
    Journal Article